Tubular carcinoma of the breast: Clinicopathologic features and survival outcome compared with ductal carcinoma in situ

Journal of Breast Cancer

Volumn 16, Issue 4, 2013, Pages 404-409

  Min, Yejin ^a   Bae, Soo Youn ^a   Lee, Hyun Chul ^a   Lee, Jun Ho ^a   Kim, Minkuk ^a   Kim, Jiyoung ^a   Lee, Se Kyung ^a   Kil, Won Ho ^a   Kim, Seok Won ^a   Lee, Jeong Eon ^a   Nam, Seok Jin ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Breast neoplams; Ductal carcinoma in situ; Lymph nodes; Tubular

Indexed keywords

EID: 84892594706     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2013.16.4.404     Document Type: Article

References (29)

1. Sullivan T, Raad RA, Goldberg S, Assaad SI, Gadd M, Smith BL, et al. Tubular carcinoma of the breast: a retrospective analysis and review of the literature. Breast Cancer Res Treat 2005;93:199-205.
2. Cabral AH, Recine M, Paramo JC, McPhee MM, Poppiti R, Mesko TW. Tubular carcinoma of the breast: an institutional experience and review of the literature. Breast J 2003;9:298-301.
3. Rakha EA, Lee AH, Evans AJ, Menon S, Assad NY, Hodi Z, et al. Tubular carcinoma of the breast: further evidence to support its excellent prognosis. J Clin Oncol 2010;28:99-104.
4. Cooper HS, Patchefsky AS, Krall RA. Tubular carcinoma of the breast. Cancer 1978;42:2334-42.
5. McDivitt RW, Boyce W, Gersell D. Tubular carcinoma of the breast: clinical and pathological observations concerning 135 cases. Am J Surg Pathol 1982;6:401-11.
6. Leibman AJ, Lewis M, Kruse B. Tubular carcinoma of the breast: mammographic appearance. AJR Am J Roentgenol 1993;160:263-5.
7. Livi L, Paiar F, Meldolesi E, Talamonti C, Simontacchi G, Detti B, et al. Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients. Eur J Surg Oncol 2005;31:9-12.
8. Fedko MG, Scow JS, Shah SS, Reynolds C, Degnim AC, Jakub JW, et al. Pure tubular carcinoma and axillary nodal metastases. Ann Surg Oncol 2010;17 Suppl 3:338-42.
9. Diab SG, Clark GM, Osborne CK, Libby A, Allred DC, Elledge RM. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol 1999;17:1442-8.
10. Javid SH, Smith BL, Mayer E, Bellon J, Murphy CD, Lipsitz S, et al. Tubular carcinoma of the breast: results of a large contemporary series. Am J Surg 2009;197:674-7.
11. Kader HA, Jackson J, Mates D, Andersen S, Hayes M, Olivotto IA. Tubular carcinoma of the breast: a population-based study of nodal metastases at presentation and of patterns of relapse. Breast J 2001;7:8-13.
12. Fernandez-Aguilar S, Noël JC. Expression of cathepsin D and galectin 3 in tubular carcinomas of the breast. APMIS 2008;116:33-40.
13. Abdel-Fatah TM, Powe DG, Hodi Z, Lee AH, Reis-Filho JS, Ellis IO. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol 2007;31:417-26.
14. Aulmann S, Elsawaf Z, Penzel R, Schirmacher P, Sinn HP. Invasive tubular carcinoma of the breast frequently is clonally related to flat epithelial atypia and low-grade ductal carcinoma in situ. Am J Surg Pathol 2009;33:1646-53.
15. Kunju LP, Ding Y, Kleer CG. Tubular carcinoma and grade 1 (well-differentiated) invasive ductal carcinoma: comparison of flat epithelial atypia and other intra-epithelial lesions. Pathol Int 2008;58:620-5.
16. Man S, Ellis IO, Sibbering M, Blamey RW, Brook JD. High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. Cancer Res 1996; 56:5484-9.
17. Winchester DJ, Sahin AA, Tucker SL, Singletary SE. Tubular carcinoma of the breast: predicting axillary nodal metastases and recurrence. Ann Surg 1996;223:342-7.
18. Stalsberg H, Hartmann WH. The delimitation of tubular carcinoma of the breast. Hum Pathol 2000;31:601-7.
19. Hansen CJ, Kenny L, Lakhani SR, Ung O, Keller J, Tripcony L, et al. Tubular breast carcinoma: an argument against treatment de-escalation. J Med Imaging Radiat Oncol 2012;56:116-22.
20. McBoyle MF, Razek HA, Carter JL, Helmer SD. Tubular carcinoma of the breast: an institutional review. Am Surg 1997;63:639-44.
21. Shin HJ, Kim HH, Kim SM, Kim DB, Lee YR, Kim MJ, et al. Pure and mixed tubular carcinoma of the breast: mammographic and sonographic differential features. Korean J Radiol 2007;8:103-10.
22. Abdel-Fatah TM, Powe DG, Hodi Z, Reis-Filho JS, Lee AH, Ellis IO. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol 2008;32:513-23.
23. Fernandez-Aguilar S, Jondet M, Simonart T, Nöel JC. Microvessel and lymphatic density in tubular carcinoma of the breast: comparative study with invasive low-grade ductal carcinoma. Breast 2006;15:782-5.
24. Fernández-Aguilar S, Simon P, Buxant F, Simonart T, Noël JC. Tubular carcinoma of the breast and associated intra-epithelial lesions: a comparative study with invasive low-grade ductal carcinomas. Virchows Arch 2005;447:683-7.
25. Fasano M, Vamvakas E, Delgado Y, Inghirami G, Mitnick J, Roses D, et al. Tubular carcinoma of the breast: immunohistochemical and DNA flow cytometric profile. Breast J 1999;5:252-255.
26. Dejode M, Sagan C, Campion L, Houvenaeghel G, Giard S, Rodier JF, et al. Pure tubular carcinoma of the breast and sentinel lymph node biopsy: a retrospective multi-institutional study of 234 cases. Eur J Surg Oncol 2013;39:248-54.
27. Clinical practice guidelines in oncology - v.3.2013. National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed August 12th, 2013.
28. Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 2007;25:3657-63.
29. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006;98:599-609.